Most Read Articles
Stephen Padilla, 22 Oct 2020
The reproductive profile of women from menarche to menopause contributes to their future risk of cardiovascular disease (CVD), suggests a recent study.

NT-proBNP, hsTNT linked to aortic valve disease in patients with bicuspid aortic valve

16 Aug 2020

Elevated levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and high-sensitivity troponin T (hsTNT) appear to increase the risk of aortic valve disease in patients with a bicuspid aortic valve (BAV), a recent study has shown.

The study included 183 BAV patients (median age, 34 years; 45 percent female) from whom venous blood samples were drawn and biomarker levels were measured using the appropriate assays. Fifty patients were found to have moderate-or-severe aortic valve regurgitation, 80 had aortic valve stenosis, and 89 had aortic dilatation.

Twenty percent (n=37) of the participants had elevated levels of NT-proBNP, six percent (n=10) had high hsTNT, and seven percent (n=12) had elevated high-sensitivity C-reactive protein (hs-CRP).

Multivariable linear regression analysis showed that a twofold increase in hsTNT concentration correlated with an increased risk of developing a one-grade higher aortic regurgitation (odds ratio [OR], 1.34, 95 percent confidence interval [CI], 1.01–1.76; p=0.041). HsTNT levels were significantly higher in patients with moderate/severe aortic valve regurgitation as compared to those without regurgitation.

Similarly, a twofold increase in NT-proBNP correlated with a 0.17-m/s (95 percent CI, 0.07–0.28) jump in maximal velocity and greater likelihood of developing one higher level of aortic regurgitation (OR, 1.41, 95 percent CI, 1.11–1.79). NT-proBNP was also significantly greater in patients with severe vs no aortic valve stenosis.

“No independent association between hsCRP and transformation growth factor beta-1 with the degree of aortic valve stenosis or regurgitation, left ventricular ejection fraction, or aortic diameter was found,” the researchers said. “This is the first step toward the identification of a biomarker that can be used in prognostic staging and risk prediction.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 22 Oct 2020
The reproductive profile of women from menarche to menopause contributes to their future risk of cardiovascular disease (CVD), suggests a recent study.